Efficacy of treatment of inflammatory cytologic abnormalities detected by papanicolaou smears: a pilot study.

OBJECTIVE: To evaluate the efficacy of metronidazole versus no treatment for the empiric treatment of inflammatory cytologic changes. MATERIALS AND METHODS: Patients with inflammatory changes on Pap smear were serially assigned to receive no treatment or metronidazole by one of three regimens: 2 grams orally as a single dose, 500 milligrams orally twice daily for 7 days, or 5 grams (in gel form) vaginally twice daily for 5 days. Smears were repeated 3 months after treatment. RESULTS: The repeat smear was normal in 47 of 63 patients treated with a single dose, 40 of 62 patients treated orally for 7 days, 14 of 21 patients treated with vaginal gel, and 29 of 49 of the control group. Chi-square analysis showed no statistical significance between groups. CONCLUSION: There is no statistically significant difference in the resolution of cytologic inflammatory changes among the study groups. Empiric metronidazole treatment has no benefit.

Behavioral effects of mid-pregnancy administration of lidocaine and mepivacaine in the rat.

Sperm-positive female Long-Evans hooded rats were injected with 6 mg/kg lidocaine (with epinephrine), 6 mg/kg mepivacaine, or saline, into the masseter muscle of the jaw on Day 11 of gestation. Birth, growth, and litter composition were unaffected by the drug treatment, as was shuttle box acquisition. Offspring of drug-treated dams had longer latencies than controls on the first day of negative geotaxis training, and were more sensitive to electric footshock. Lidocaine-dosed offspring responded less in the presence of the correct cue in the visual discrimination task, and mepivacaine-dosed animals were hypoactive in the open field. In a second study, offspring of lidocaine-dosed dams were slower to develop the righting reflex, made more errors in acquiring a water maze, had longer suppression times in a conditioned suppression task, and had longer latencies in the tail flick test. Dosing had no effect upon birth and growth, shuttle box, or footshock sensitivity. These data demonstrate that midgestational exposure to lidocaine or mepivacaine at a dose near the limits of permissible human exposure produces significant behavioral changes in the offspring. This preliminary study suggests that development of some portion of the central nervous system is altered by such exposure. Further work is required to determine the parameters and the extent of the effect.